MARC record from Internet Archive

LEADER: 02245cam 2200553Ia 4500
001 ocm30514236
003 OCoLC
005 20200510192936.0
008 940504s1994 enka b 001 0 eng
010 $a 88001432
040 $aUKM$beng$cUKM$dGGN$dOCLCQ$dBAKER$dOCLCG$dYDXCP$dZWZ$dOCLCQ$dOCLCO$dUKMGB$dUKBTH
015 $aGB9434578$2bnb
016 7 $a006215215$2Uk
020 $a0192621343
020 $a9780192621344
035 $a(OCoLC)30514236
050 4 $aRM666.E548$bD473 1994
080 0 $a615.205
082 04 $a615.7$220
245 00 $aDesign of enzyme inhibitors as drugs /$cedited by Merton Sandler and H. John Smith.
260 $aOxford [England] ;$aNew York :$bOxford University Press,$c1994.
300 $axx, 827 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 1 $aVol. 2. 1994.
520 $aA text on the developments in the design of enzyme inhibitors as potent drugs for the treatment of disease and infection. This type of drug exerts its action by modifying a particular body function or combating an infection by blocking the action of a specific enzyme.
540 $aCurrent Copyright Fee: GBP20.00$c0.$5Uk
650 0 $aEnzyme inhibitors$xTherapeutic use$xTesting.
650 0 $aEnzyme inhibitors$xStructure-activity relationships.
650 7 $aChimie pharmaceutique.$2fmesh
650 7 $aAntienzymes.$2fmesh
650 7 $aAntienzymes$xusage the rapeutique.$2fmesh
650 7 $aAntienzymes.$2ram
650 7 $aAntienzymes$xEmploi en the rapeutique$xEssais.$2ram
650 7 $aAntienzymes$xRelations structure-activite .$2ram
650 7 $aChimie pharmaceutique.$2ram
653 0 $aHumans$aEffects of$aDrugs.
700 1 $aSandler, Merton.
700 1 $aSmith, H. J.,$d1930-
938 $aBaker & Taylor$bBKTY$c165.00$d165.00$i0192621343$n0002468495$sactive
938 $aYBP Library Services$bYANK$n95947
029 1 $aAU@$b000010700877
029 1 $aDEBBG$bBV009871307
029 1 $aZWZ$b019069057
029 1 $aUKMGB$b006215215
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 30 OTHER HOLDINGS